Clinical Trial Update: Adherence to Minimally Invasive Testing

View source ↗

Summary

This completed trial evaluated adherence to a minimally invasive test for colorectal cancer screening. The study is sponsored by Epigenomics, Inc and is listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Epigenomics, Inc | Conditions: Colorectal Cancer | Status: COMPLETED